secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bicara Therapeutics Inc. (BCAX)
CIK:        0002023658
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001193125-24-219617
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicara Therapeutics files amended charter and bylaws post-IPO, increases authorized shares to 500M
--------------------------------------------------------------------------------

- Authorized 500 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated stockholder ability to act by written consent and to call special meetings.
- Established advance notice procedures for stockholder proposals and director nominations.
- Amendments effective immediately prior to completion of IPO, as previously disclosed in S-1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/0001193125-24-219617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023658/000119312524219617/d844648d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-219617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer